Oscar Health, Inc.
OSCR
$16.80
$1.388.95%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.06% | 42.37% | 67.44% | 68.61% | 46.01% |
| Total Other Revenue | 24.20% | -23.15% | -15.93% | -11.59% | 2.87% |
| Total Revenue | 29.04% | 42.20% | 67.11% | 68.30% | 45.86% |
| Cost of Revenue | 49.41% | 45.34% | 71.34% | 72.28% | 44.56% |
| Gross Profit | -39.10% | 33.88% | 44.56% | 51.56% | 50.39% |
| SG&A Expenses | 22.81% | 22.48% | 27.92% | 41.28% | 29.05% |
| Depreciation & Amortization | -8.30% | -13.84% | 19.26% | -18.40% | -13.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.82% | 40.50% | 61.06% | 64.98% | 40.80% |
| Operating Income | -439.89% | 60.12% | -1.55% | 16.95% | 1,138.63% |
| Income Before Tax | -483.17% | 61.48% | -2.02% | 19.26% | 527.38% |
| Income Tax Expenses | -208.80% | 1,175.60% | 49.88% | 126.89% | 298.37% |
| Earnings from Continuing Operations | -505.76% | 55.23% | -2.30% | 17.22% | 465.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 223.81% | -106.14% | -36.46% | -168.20% | -1.94% |
| Net Income | -506.29% | 55.20% | -2.34% | 16.52% | 461.97% |
| EBIT | -439.89% | 60.12% | -1.55% | 16.95% | 1,138.63% |
| EBITDA | -396.39% | 57.14% | -0.55% | 16.67% | 3,188.84% |
| EPS Basic | -479.49% | 42.94% | 6.37% | 23.37% | 432.63% |
| Normalized Basic EPS | -458.48% | 48.68% | 6.62% | 24.88% | 487.35% |
| EPS Diluted | -537.87% | 47.21% | -3.57% | 23.37% | 388.28% |
| Normalized Diluted EPS | -556.56% | 55.02% | 6.62% | 24.88% | 404.14% |
| Average Basic Shares Outstanding | 7.06% | 8.57% | 9.30% | 8.97% | 8.78% |
| Average Diluted Shares Outstanding | -15.93% | 4.13% | 9.30% | 8.97% | 38.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |